Thrive Bioscience Leadership

Alan Blanchard is a CSO at Thrive Bioscience, Inc. and is based in Beverly, Massachusetts. He has worked as Director Research at AGENCOURT PERSONAL GENOMICS, Senior Director Technology Development at Rosetta Inpharmatics, and Post-doc at University of Washington. Alan P. studied at California Institute of Technology- Caltech between 1976 and 1980 and California Institute of Technology- Caltech between 1984 and 1992.

➢ Entrepreneurial senior executive & board member with extensive experience identifying, positioning, financing and managing early stage, innovative, technology & life science companies➢ Directly involved in founding 11 companies➢ Significant transaction experience -- directly involved in raising over $200 million of private company early stage financing, $420 million of public equity offerings & $2.4 billion of M&A transactions➢ Currently Co-Founder, President & Board Member of Thrive Bioscience, Inc., (previously unavailable solutions to automate, with analytics, cell and stem cell culture)Previously:➢ Executive Director of Trust for Science & Technology, investing in technology companies & commercializing research, based in San Juan & Boston ➢ President & COO of Indevus Pharmaceuticals (NASD: IDEV; acquired by Endo) providing pharmaceuticals & devices to urologists & endocrinologists ➢ EVP & CFO, Interneuron Pharmaceuticals (NASDAQ: IPIC),neurology specialty pharmaceuticals➢ CFO & VP of Corporate Development & Strategic Planning, Cytyc Corporation (NASDAQ: CYTC; acquired by Hologic)➢ Board Member, investor & advisor to life sciences & technology companies, including: HNC Software, Fair Isaac, Redwood Trust, Saf-T-Med, Health Dialog, Exact Sciences, Symon Communications & numerous non-profitsEmail: [email protected]

Alan Blanchard is a CSO at Thrive Bioscience, Inc. and is based in Beverly, Massachusetts. He has worked as Director Research at AGENCOURT PERSONAL GENOMICS, Senior Director Technology Development at Rosetta Inpharmatics, and Post-doc at University of Washington. Alan P. studied at California Institute of Technology- Caltech between 1976 and 1980 and California Institute of Technology- Caltech between 1984 and 1992.

➢ Entrepreneurial senior executive & board member with extensive experience identifying, positioning, financing and managing early stage, innovative, technology & life science companies➢ Directly involved in founding 11 companies➢ Significant transaction experience -- directly involved in raising over $200 million of private company early stage financing, $420 million of public equity offerings & $2.4 billion of M&A transactions➢ Currently Co-Founder, President & Board Member of Thrive Bioscience, Inc., (previously unavailable solutions to automate, with analytics, cell and stem cell culture)Previously:➢ Executive Director of Trust for Science & Technology, investing in technology companies & commercializing research, based in San Juan & Boston ➢ President & COO of Indevus Pharmaceuticals (NASD: IDEV; acquired by Endo) providing pharmaceuticals & devices to urologists & endocrinologists ➢ EVP & CFO, Interneuron Pharmaceuticals (NASDAQ: IPIC),neurology specialty pharmaceuticals➢ CFO & VP of Corporate Development & Strategic Planning, Cytyc Corporation (NASDAQ: CYTC; acquired by Hologic)➢ Board Member, investor & advisor to life sciences & technology companies, including: HNC Software, Fair Isaac, Redwood Trust, Saf-T-Med, Health Dialog, Exact Sciences, Symon Communications & numerous non-profitsEmail: [email protected]

Alan Blanchard is a CSO at Thrive Bioscience, Inc. and is based in Beverly, Massachusetts. He has worked as Director Research at AGENCOURT PERSONAL GENOMICS, Senior Director Technology Development at Rosetta Inpharmatics, and Post-doc at University of Washington. Alan P. studied at California Institute of Technology- Caltech between 1976 and 1980 and California Institute of Technology- Caltech between 1984 and 1992.

➢ Entrepreneurial senior executive & board member with extensive experience identifying, positioning, financing and managing early stage, innovative, technology & life science companies➢ Directly involved in founding 11 companies➢ Significant transaction experience -- directly involved in raising over $200 million of private company early stage financing, $420 million of public equity offerings & $2.4 billion of M&A transactions➢ Currently Co-Founder, President & Board Member of Thrive Bioscience, Inc., (previously unavailable solutions to automate, with analytics, cell and stem cell culture)Previously:➢ Executive Director of Trust for Science & Technology, investing in technology companies & commercializing research, based in San Juan & Boston ➢ President & COO of Indevus Pharmaceuticals (NASD: IDEV; acquired by Endo) providing pharmaceuticals & devices to urologists & endocrinologists ➢ EVP & CFO, Interneuron Pharmaceuticals (NASDAQ: IPIC),neurology specialty pharmaceuticals➢ CFO & VP of Corporate Development & Strategic Planning, Cytyc Corporation (NASDAQ: CYTC; acquired by Hologic)➢ Board Member, investor & advisor to life sciences & technology companies, including: HNC Software, Fair Isaac, Redwood Trust, Saf-T-Med, Health Dialog, Exact Sciences, Symon Communications & numerous non-profitsEmail: [email protected]